ANDREWS RONALD ASBURY
SEC CIK 1299153 · EDGAR
BoughtSold
Most active insiders at CNSY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sims Andrew John Hugh MacIntyre | CFO | $10.2K | — |
| 2 | Clowes Howard | Dir | — | — |
| 3 | van Es-Johansson An | Dir | — | — |
| 4 | Guse Kyle | Dir | — | — |
| 5 | Hawkins Richard J | Dir | — | — |
| 6 | ANDREWS RONALD ASBURY | Dir | — | — |
| 7 | HEDRICK MARC H | CEO, Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-01 16:30 | 2026-07-01 | CNSY | CERENOME, INC. | ANDREWS RONALD ASBURY | Dir | M - OptEx | $0.00 | +922 | 922 | New | $0 |
| A | 2026-01-20 | 2025-10-15 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Dir | A - Grant | $17.58 | +568 | 15.8K | +4% | +$9,985 |
| 2025-10-16 | 2025-10-15 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Dir | A - Grant | $17.58 | +568 | 15.7K | +4% | +$9,985 | |
| 2025-07-18 | 2025-07-16 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Dir | A - Grant | $14.78 | +676 | 15.2K | +5% | +$9,991 | |
| 2025-04-17 | 2025-04-15 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Dir | A - Grant | $5.60 | +1,785 | 14.6K | +14% | +$9,996 | |
| 2025-01-16 | 2025-01-15 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Dir | A - Grant | $6.10 | +1,639 | 12.8K | +15% | +$9,998 | |
| 2024-10-17 | 2024-10-15 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Dir | A - Grant | $6.62 | +1,510 | 11.1K | +16% | +$9,996 | |
| 2024-07-16 | 2024-07-15 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Dir | A - Grant | $4.63 | +2,157 | 9,618 | +29% | +$9,987 | |
| 2024-04-17 | 2024-04-15 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Dir | A - Grant | $6.66 | +3,153 | 7,461 | +73% | +$21.0K | |
| 2023-10-26 | 2023-10-24 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Dir | A - Grant | — | +4,005 | 4,308 | +1,322% | — | |
| 2023-09-14 | 2023-09-12 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Dir | A - Grant | — | +6,060 | 6,060 | New | — | |
| D | 2022-12-09 | 2022-12-01 | IMDX | Insight Molecular Diagnostics Inc. | ANDREWS RONALD ASBURY | Former CEO, Dir | M - OptEx | $0.00 | +250.0K | 583.2K | +75% | $0 |
| 2022-08-18 | 2022-08-16 | IMDX | Insight Molecular Diagnostics Inc. | ANDREWS RONALD ASBURY | Pres, CEO, Dir | P - Purchase | $0.96 | +40.0K | 333.2K | +14% | +$38.4K | |
| 2022-03-17 | 2022-03-16 | IMDX | Insight Molecular Diagnostics Inc. | ANDREWS RONALD ASBURY | CEO, Dir | P - Purchase | $1.28 | +50.0K | 293.2K | +21% | +$64.0K | |
| D | 2021-07-02 | 2021-06-30 | IMDX | Insight Molecular Diagnostics Inc. | ANDREWS RONALD ASBURY | CEO, Dir | F - Tax | $0.00 | -25.9K | 194.0K | -12% | $0 |
| D | 2021-07-02 | 2021-05-07 | IMDX | Insight Molecular Diagnostics Inc. | ANDREWS RONALD ASBURY | CEO, Dir | M - OptEx | $0.00 | +106.2K | 219.9K | +93% | $0 |
| D | 2021-07-02 | 2021-07-01 | IMDX | Insight Molecular Diagnostics Inc. | ANDREWS RONALD ASBURY | CEO, Dir | F - Tax | $0.00 | -15.8K | 243.2K | -6% | $0 |
| D | 2021-07-02 | 2021-07-01 | IMDX | Insight Molecular Diagnostics Inc. | ANDREWS RONALD ASBURY | CEO, Dir | M - OptEx | $0.00 | +65.0K | 259.0K | +33% | $0 |
Purchase Sale Sale after option exercise All abbreviations